These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12711452)

  • 1. Lipid microparticles as sustained release system for a GnRH antagonist (Antide).
    Del Curto MD; Chicco D; D'Antonio M; Ciolli V; Dannan H; D'Urso S; Neuteboom B; Pompili S; Schiesaro S; Esposito P
    J Control Release; 2003 Apr; 89(2):297-310. PubMed ID: 12711452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding kinetics of the long-acting gonadotropin-releasing hormone (GnRH) antagonist antide to rat pituitary GnRH receptors.
    Li SL; Vuagnat B; Gruaz NM; Eshkol A; Sizonenko PC; Aubert ML
    Endocrinology; 1994 Jul; 135(1):45-52. PubMed ID: 8013383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivesicular liposome (MVL) sustained delivery of a novel synthetic cationic GnRH antagonist for prostate cancer treatment.
    Wang T; Gao L; Quan D
    J Pharm Pharmacol; 2011 Jul; 63(7):904-10. PubMed ID: 21635255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. II. Development of an in vitro bioassay for characterization of pharmacokinetics and pharmacodynamics of antide in circulation.
    Danforth DR; Williams RF; Gordon K; Leal JA; Hodgen GD
    Endocrinology; 1991 Apr; 128(4):2041-4. PubMed ID: 1900785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone antagonist for postpartum contraception: outcome for the mother and male offspring in the marmoset.
    Fraser HM; Recio R; Conn PM; Lunn SF
    J Clin Endocrinol Metab; 1994 Jan; 78(1):121-5. PubMed ID: 8288695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels.
    Huirne JA; van Loenen AC; Schats R; McDonnell J; Hompes PG; Schoemaker J; Homburg R; Lambalk CB
    Hum Reprod; 2004 Oct; 19(10):2206-15. PubMed ID: 15333605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. I. In vitro studies on mechanism of action.
    Danforth DR; Williams RF; Gordon K; Hodgen GD
    Endocrinology; 1991 Apr; 128(4):2036-40. PubMed ID: 1900784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antide (Nal-Lys GnRH antagonist) suppression of pituitary-testicular function and sexual behavior in group-living rhesus monkeys.
    Wallen K; Eisler JA; Tannenbaum PL; Nagell KM; Mann DR
    Physiol Behav; 1991 Aug; 50(2):429-35. PubMed ID: 1745690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of testicular and epididymal functions in a non-human primate (bonnet monkey) by combined administration of a gonadotropin-releasing hormone antagonist and testosterone buciclate.
    Rajalakshmi M; Kumar PK; Kinger S; Pal PC; Pruthi JS; Bajaj JS
    Contraception; 1995 Dec; 52(6):381-8. PubMed ID: 8749603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended presence of antide (Nal-Lys GnRH antagonist) in circulation: prolonged duration of gonadotropin inhibition may derive from antide binding to serum proteins.
    Danforth DR; Gordon K; Leal JA; Williams RF; Hodgen GD
    J Clin Endocrinol Metab; 1990 Feb; 70(2):554-6. PubMed ID: 2298867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose long-term suppression of testosterone secretion by a gonadotropin-releasing hormone antagonist (Antide) in male monkeys.
    Edelstein MC; Gordon K; Williams RF; Danforth DR; Hodgen GD
    Contraception; 1990 Aug; 42(2):209-14. PubMed ID: 2085971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer.
    Steinberg M
    Clin Ther; 2009; 31 Pt 2():2312-31. PubMed ID: 20110043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual maturation in male rhesus monkeys: importance of neonatal testosterone exposure and social rank.
    Mann DR; Akinbami MA; Gould KG; Paul K; Wallen K
    J Endocrinol; 1998 Mar; 156(3):493-501. PubMed ID: 9582506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay of Antarelix, a luteinizing hormone releasing-hormone antagonist, in plasma and its application for pharmacokinetic study in dogs.
    Sorensen S; Rondeau JJ; Lenaerts V; Boutignon F; Wüthrich P; Deghenghi R; Adam A; Ong H
    J Immunoassay; 1996 Aug; 17(3):205-26. PubMed ID: 8842981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Orntide microspheres in a rat animal model and correlation to in vitro release profiles.
    Kostanski JW; Dani BA; Reynolds GA; Bowers CY; DeLuca PP
    AAPS PharmSciTech; 2000 Oct; 1(4):E27. PubMed ID: 14727892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titrating luteinizing hormone replacement to sustain the structure and function of the corpus luteum after gonadotropin-releasing hormone antagonist treatment in rhesus monkeys.
    Duffy DM; Stewart DR; Stouffer RL
    J Clin Endocrinol Metab; 1999 Jan; 84(1):342-9. PubMed ID: 9920105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of LHRH antagonists suitable for oral administration via the vitamin B12 uptake system.
    Russell-Jones GJ; Westwood SW; Farnworth PG; Findlay JK; Burger HG
    Bioconjug Chem; 1995; 6(1):34-42. PubMed ID: 7711102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular atresia and infertility in rats treated with a gonadotropin-releasing hormone antagonist.
    Sharpe KL; Bertero MC; Lyon BP; Muse KN; Vernon MW
    Endocrinology; 1990 Jul; 127(1):25-31. PubMed ID: 2113868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.